Georgia Nephrology

Lawrenceville, Georgia 30046

3 studies enrolling now · 8 studies all time

What they study most

End Stage Kidney Disease, FSGS, Focal Segmental Glomerulosclerosis (FSGS), IgA Nephropathy, Lupus Erythematosus, Lupus Nephritis, Primary Membranous Nephropathy, Proteinuric Kidney Disease

Studies at this site

• Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) — Recruiting now
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy — Recruiting now
• A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis — Running, not enrolling
• Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis — Completed
• Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities — Running, not enrolling
• A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS) — Stopped early